
Sign up to save your podcasts
Or


In this episode, Duane Mancini welcomes to the show Aaron DeGagne, Healthcare Senior Analyst at PitchBook. From quarterly reports to market dynamics, Aaron sheds light on significant healthcare investments, including the rise in surgical tools, devices, and the blurring lines between healthtech and medtech. They delve into the impact of global market uncertainties, interest rates, and the noteworthy deals like Neuralink’s $600 million raise. The conversation also explores themes like consumer health advancements, cancer diagnostics, and the potential shifts in IPO activities.
Aaron DeGagne LinkedIn
PitchBook Website
Duane Mancini LinkedIn
Project Medtech Website
Project Medtech LinkedIn
By Project Medtech5
2323 ratings
In this episode, Duane Mancini welcomes to the show Aaron DeGagne, Healthcare Senior Analyst at PitchBook. From quarterly reports to market dynamics, Aaron sheds light on significant healthcare investments, including the rise in surgical tools, devices, and the blurring lines between healthtech and medtech. They delve into the impact of global market uncertainties, interest rates, and the noteworthy deals like Neuralink’s $600 million raise. The conversation also explores themes like consumer health advancements, cancer diagnostics, and the potential shifts in IPO activities.
Aaron DeGagne LinkedIn
PitchBook Website
Duane Mancini LinkedIn
Project Medtech Website
Project Medtech LinkedIn

30,711 Listeners

4,168 Listeners

1,288 Listeners

4,350 Listeners

9,572 Listeners

92 Listeners

9,530 Listeners

1,423 Listeners

226 Listeners

68 Listeners

6,094 Listeners

9,935 Listeners

444 Listeners

15,261 Listeners

1,660 Listeners